首页> 外文期刊>Experimental & Molecular Pathology >Quantitative evaluation of SPRR3 expression in esophageal squamous cell carcinoma by qPCR and its potential use as a biomarker.
【24h】

Quantitative evaluation of SPRR3 expression in esophageal squamous cell carcinoma by qPCR and its potential use as a biomarker.

机译:通过qPCR定量评估食道鳞状细胞癌中SPRR3表达的潜力及其作为生物标志物的潜在用途。

获取原文
获取原文并翻译 | 示例
       

摘要

Esophageal squamous cell carcinoma (ESCC) is highly fatal due to late diagnosis and inefficient treatment. Early disease detection could improve diagnosis and patient survival. Esophageal squamous epithelial cells express SPRR3, a member of the small proline-rich protein family, which is downregulated in ESCC. Therefore, SPRR3 expression may be used as a biomarker to follow the transition from healthy mucosa to ESCC. Both SPRR3 mRNA splice variants, v1 and v2, were evaluated by real time PCR in tumor and histologically normal adjacent tissue biopsies from 84 ESCC patients and 18 healthy controls. SPRR3-v1 was most highly expressed in the esophageal mucosa of healthy subjects, with an increasingly lower expression in the adjacent mucosa of ESCC patients and in tumors, respectively. SPRR3-v2 expression was low in normal mucosa and in tumors but it was higher in the adjacent mucosa of ESCC patients. In addition, we found a significant correlation between a lower SPRR3-v1 and SPRR3-v2 expression and age and alcohol consumption, respectively. SPRR3 protein expression presented a good correlation with SPRR3 mRNA expression. Cut-off points to discriminate between healthy mucosa, tumor and adjacent mucosa were determined with receiver operating characteristic (ROC) curves. This analysis showed that SPRR3-v1 expression discriminates the esophageal mucosa of healthy subjects from the adjacent mucosa and the tumor of ESCC patients with high sensitivity and specificity. Our data shows that the quantitative analysis of SPRR3 mRNA is a robust and reliable method to monitor the malignant transformation of the healthy esophageal mucosa into ESCC.
机译:食管鳞状细胞癌(ESCC)由于诊断迟钝和治疗效率低而致死。早期疾病检测可以改善诊断和患者生存率。食管鳞状上皮细胞表达SPRR3,SPRR3是富含脯氨酸的小蛋白家族的一员,在ESCC中被下调。因此,SPRR3表达可以用作生物标记,以追踪从健康黏膜到ESCC的转变。通过实时PCR在来自84位ESCC患者和18位健康对照的肿瘤和组织学正常的邻近组织活检中评估了两个SPRR3 mRNA剪接变体v1和v2。 SPRR3-v1在健康受试者的食管粘膜中表达最高,而在ESCC患者的邻近粘膜和肿瘤中的表达分别越来越低。在正常黏膜和肿瘤中,SPRR3-v2表达较低,但在ESCC患者的邻近黏膜中较高。此外,我们发现较低的SPRR3-v1和SPRR3-v2表达与年龄和饮酒量之间存在显着相关性。 SPRR3蛋白表达与SPRR3 mRNA表达具有良好的相关性。用受试者工作特征(ROC)曲线确定区分健康黏膜,肿瘤和邻近黏膜的临界点。该分析表明SPRR3-v1表达以高灵敏度和特异性将健康受试者的食道粘膜与邻近的粘膜和ESCC患者的肿瘤区分开。我们的数据表明,SPRR3 mRNA的定量分析是监测健康的食管粘膜向ESCC恶变的可靠且可靠的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号